This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2016 Jan;18 Suppl 1(Suppl 1):i1-i50.

doi: 10.1093/neuonc/nov297.

American Brain Tumor Association Adolescent and Young Adult Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012

Affiliations

Affiliations

¹ Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH USA Central Brain Tumor Registry of the United States, Hinsdale, IL USA.
² Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH USA Department of Pediatric Hematology-Oncology, Rainbow Babies and Children s Hospital, Cleveland, OH USA.
³ Division of Hematology, Oncology and BMT, Nationwide Children's Hospital and The Ohio State University, Columbus, OH USA.
⁴ School of Public Health, University of Memphis, Memphis, TN USA.
⁵ Keck School of Medicine, University of Southern California, Los Angeles, CA USA.
⁶ Department of Pediatric Hematology and Oncology, Cleveland Clinic Children's Hospital, Cleveland, OH USA.
⁷ Solon High School, Solon, OH USA.
⁸ Central Brain Tumor Registry of the United States, Hinsdale, IL USA.

PMID: 26705298
PMCID: PMC4690545
DOI: 10.1093/neuonc/nov297

American Brain Tumor Association Adolescent and Young Adult Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012

Quinn T Ostrom et al. Neuro Oncol. 2016 Jan.

. 2016 Jan;18 Suppl 1(Suppl 1):i1-i50.

doi: 10.1093/neuonc/nov297.

Affiliations

¹ Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH USA Central Brain Tumor Registry of the United States, Hinsdale, IL USA.
² Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH USA Department of Pediatric Hematology-Oncology, Rainbow Babies and Children s Hospital, Cleveland, OH USA.
³ Division of Hematology, Oncology and BMT, Nationwide Children's Hospital and The Ohio State University, Columbus, OH USA.
⁴ School of Public Health, University of Memphis, Memphis, TN USA.
⁵ Keck School of Medicine, University of Southern California, Los Angeles, CA USA.
⁶ Department of Pediatric Hematology and Oncology, Cleveland Clinic Children's Hospital, Cleveland, OH USA.
⁷ Solon High School, Solon, OH USA.
⁸ Central Brain Tumor Registry of the United States, Hinsdale, IL USA.

PMID: 26705298
PMCID: PMC4690545
DOI: 10.1093/neuonc/nov297

No abstract available

PubMed Disclaimer

Figures

Fig. 1. — Fig. 1.
Average Annual Age-Adjusted Incidence Rates for the Five Most Common Cancers in Persons Age A) 15-39 Years, B) 15-19 Years, C) 20-24 Years, D) 25-29 Years, E) 30-34 Years, and F) 35-39 Years, (CBTRUS 2008-2012 and USCS 2008-2012).

Fig. 2. — Fig. 2.
Average Annual Age-Adjusted and Crude Mortality Rates for the Five Most Common Causes of Death Due to Cancer in Persons Age A) 15-39 Years, B) 15-19 Years, C) 20-24 Years, D) 25-29 Years, E) 30-34 Years, and F) 35-39 Years, (NVSS 2008-2012).

Fig. 3. — Fig. 3.
Average Annual Age-Adjusted Incidence Rates and Annual Average Cases^a of Primary Brain and CNS Tumors by Age Groups (15-39 Years), (CBTRUS 2008-2012).

Fig. 4a. — Fig. 4a.
Average Annual Age-Adjusted Incidence Rates of All Primary Brain and CNS Tumors by Region of the United States (Age 15-39 Years), (CBTRUS 2008-2012).

Fig. 4b. — Fig. 4b.
Average Annual Age-Adjusted Incidence Rates of All Malignant Brain and CNS Tumors by Region of the United States (Age 15-39 Years), (CBTRUS 2008-2012).

Fig. 4c. — Fig. 4c.
Average Annual Age-Adjusted Incidence Rates of All Non-Malignant Brain and CNS Tumors by Region of the United States (Age 15-39 Years), (CBTRUS 2008-2012).

Fig. 5. — Fig. 5.
Distribution^a of All Primary Brain and CNS Tumors by Site, Age 15-39 Years (Five-Year Total = 53,083), (CBTRUS 2008-2012).

Fig. 6. — Fig. 6.
Distribution^a of All Primary Brain and CNS Tumors by Site and Age Groups A) 15-19 Years (Five-Year Total = 6,747), B) 20-24 Years (Five-Year Total = 7,765), C) 25-29 Years (Five-Year Total = 10,385), D) 30-34 Years (Five-Year Total = 12,626), and E) 35-39 Years (Five-Year Total = 15,560), (CBTRUS 2008-2012).

Fig. 7. — Fig. 7.
Distribution^a of Primary Malignant Brain and CNS Tumors by Site, Age 15-39 Years (Five-Year Total = 16,742), (CBTRUS 2008-2012).

Fig. 8. — Fig. 8.
Distribution^a of Primary Malignant Brain and CNS Tumors by Site and Age Groups A) 15-19 Years (Five-Year Total = 2,747), B) 20-24 Years (Five-Year Total = 2,728), C) 25-29 Years (Five-Year Total = 3,421), D) 30-34 Years (Five-Year Total = 3,721), and E) 35-39 Years (Five-Year Total = 4,125), (CBTRUS 2008-2012).

Fig. 9. — Fig. 9.
Distribution^a of Non-Malignant Primary Brain and CNS Tumors by Site, Age 15-39 Years (Five-Year Total = 36,341), (CBTRUS 2008-2012).

Fig. 10. — Fig. 10.
Distribution^a of Non-Malignant Primary Brain and CNS Tumors by Site by Age Groups A) 15-19 Years (Five-Year Total = 4,000), B) 20-24 Years (Five-Year Total = 5,037), C) 25-29 Years (Five-Year Total = 6,964), D) 30-34 Years (Five-Year Total = 8,905), and E) 35-39 Years (Five-Year Total = 11,435), (CBTRUS 2008-2012).

Fig. 11. — Fig. 11.
Distribution^a of All Primary Brain and CNS Tumors by Histology, Age 15-39 Years (Five-Year Total = 53,083), (CBTRUS 2008-2012).

Fig. 12. — Fig. 12.
Distribution^a of All Primary Brain and CNS Tumors by Histology by Age Groups A) 15-19 Years (Five-Year Total = 6,747), B) 20-24 Years (Five-Year Total = 7,765), C) 25-29 Years (Five-Year Total = 10,385), D) 30-34 Years (Five-Year Total = 12,626), and E) 35-39 Years (Five-Year Total = 15,560), (CBTRUS 2008-2012).

Fig. 13. — Fig. 13.
Distribution^a of Primary Malignant Brain and CNS Tumors by Histology, Age 15-39 Years (Five-Year Total = 16,742), (CBTRUS 2008-2012).

Fig. 14. — Fig. 14.
Distribution^a of Primary Malignant Brain and CNS Tumors by Histology by Age Groups A) 15-19 Years (Five-Year Total = 2,747), B) 20-24 Years (Five-Year Total = 2,728), C) 25-29 Years (Five-Year Total = 3,421), D) 30-34 Years (Five-Year Total = 3,721), and E) 35-39 Years (Five-Year Total = 4,125), (CBTRUS 2008-2012).

Fig. 15. — Fig. 15.
Distribution^a of Non-Malignant Primary Brain and CNS Tumors by Histology, Age 15-39 Years (Five-Year Total = 36,341), (CBTRUS 2008-2012).

Fig. 16. — Fig. 16.
Distribution^a of Non-Malignant Primary Brain and CNS Tumors by Histology and Age Groups A) 15-19 Years (Five-Year Total = 4,000), B) 20-24 Years (Five-Year Total = 5,037), C) 25-29 Years (Five-Year Total = 6,964), D) 30-34 Years (Five-Year Total = 8,905), and E) 35-39 Years (Five-Year Total = 11,435), (CBTRUS 2008-2012).

Fig. 17. — Fig. 17.
Distribution^a of Gliomas by Site, Age 15-39 Years (Five-Year Total = 15,002), (CBTRUS 2008-2012).

Fig. 18. — Fig. 18.
Distribution^a of Gliomas by Site and Age Groups A) 15-19 Years (Five-Year Total = 2,327), B) 20-24 Years (Five-Year Total = 2,381), C) 25-29 Years (Five-Year Total = 3,112), D) 30-34 Years (Five-Year Total = 3,454), and E) 35-39 Years (Five-Year Total = 3,728), (CBTRUS 2008-2012).

Fig. 19. — Fig. 19.
Distribution^a of Gliomas by Histology, Age 15-39 Years (Five-Year Total = 15,002), (CBTRUS 2008-2012).

Fig. 20. — Fig. 20.
Distribution^a of Gliomas by Histology by Age Groups, A) 15-19 Years (Five-Year Total = 2,327), B) 20-24 Years (Five-Year Total = 2,381), C) 25-29 Years (Five-Year Total = 3,112), D) 30-34 Years (Five-Year Total = 3,454), and E) 35-39 Years (Five-Year Total = 3,728), (CBTRUS 2008-2012).

Fig. 21. — Fig. 21.
Incidence Rate Ratios by Gender (Males:Females) in Adolescents and Young Adults Age 15-39 Years for Selected CBTRUS Histology Groupings and Histologies, (CBTRUS 2008-2012).

Fig. 22. — Fig. 22.
Incidence Rate Ratios by Race (Whites:Blacks) in Adolescents and Young Adults Age 15-39 Years for Selected CBTRUS Histology Groupings and Histologies, (CBTRUS 2008-2012).

Fig. 23. — Fig. 23.
Average Annual Age-Adjusted Mortality Rates of All Malignant Brain and CNS Tumors by Region of the United States (Age 15-39 Years), (NVSS 2008-2012).

Fig. 24. — Fig. 24.
Relative Survival For 1, 2, 3, 4, 5 and 10 Years after Diagnosis with a Glioma in Persons Age 15-39 Years by A) Age Groups, B) Sex, C) Race/Ethnicity, and D) Insurance Status (data available only from 2007-2012), (SEER 1995-2012).

Fig. 25. — Fig. 25.
Five-Year Conditional Survival by Age Groups and Histology Groupings (Age 15-39 Years), (SEER 1995-2012).

See this image and copyright information in PMC

Similar articles

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015.
Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS. Ostrom QT, et al. Neuro Oncol. 2018 Oct 1;20(suppl_4):iv1-iv86. doi: 10.1093/neuonc/noy131. Neuro Oncol. 2018. PMID: 30445539 Free PMC article. Review. No abstract available.
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.
Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS. Ostrom QT, et al. Neuro Oncol. 2015 Oct;17 Suppl 4(Suppl 4):iv1-iv62. doi: 10.1093/neuonc/nov189. Epub 2015 Oct 27. Neuro Oncol. 2015. PMID: 26511214 Free PMC article. No abstract available.
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013.
Ostrom QT, Gittleman H, Xu J, Kromer C, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS. Ostrom QT, et al. Neuro Oncol. 2016 Oct 1;18(suppl_5):v1-v75. doi: 10.1093/neuonc/now207. Neuro Oncol. 2016. PMID: 28475809 Free PMC article. No abstract available.
CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010.
Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y, Stroup NE, Kruchko C, Barnholtz-Sloan JS. Ostrom QT, et al. Neuro Oncol. 2013 Nov;15 Suppl 2(Suppl 2):ii1-56. doi: 10.1093/neuonc/not151. Neuro Oncol. 2013. PMID: 24137015 Free PMC article. No abstract available.
CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009.
Dolecek TA, Propp JM, Stroup NE, Kruchko C. Dolecek TA, et al. Neuro Oncol. 2012 Nov;14 Suppl 5(Suppl 5):v1-49. doi: 10.1093/neuonc/nos218. Neuro Oncol. 2012. PMID: 23095881 Free PMC article. Review. No abstract available.

See all similar articles

Cited by

Adolescent and young adult neuro-oncology: a comprehensive review.
Yeo KK, Burgers DE, Brodigan K, Fasciano K, Frazier AL, Warren KE, Reardon DA. Yeo KK, et al. Neurooncol Pract. 2021 Feb 18;8(3):236-246. doi: 10.1093/nop/npab001. eCollection 2021 Jun. Neurooncol Pract. 2021. PMID: 34055371 Free PMC article. Review.
Ependymoma, NOS and anaplastic ependymoma incidence and survival in the United States varies widely by patient and clinical characteristics, 2000-2016.
Achey RL, Vo S, Cioffi G, Gittleman H, Schroer J, Khanna V, Buerki R, Kruchko C, Barnholtz-Sloan JS. Achey RL, et al. Neurooncol Pract. 2020 May 9;7(5):549-558. doi: 10.1093/nop/npaa023. eCollection 2020 Oct. Neurooncol Pract. 2020. PMID: 33014396 Free PMC article.
Receptor-Targeted Glial Brain Tumor Therapies.
Sharma P, Debinski W. Sharma P, et al. Int J Mol Sci. 2018 Oct 25;19(11):3326. doi: 10.3390/ijms19113326. Int J Mol Sci. 2018. PMID: 30366424 Free PMC article. Review.
Immunovirotherapy for Pediatric Solid Tumors: A Promising Treatment That is Becoming a Reality.
de la Nava D, Selvi KM, Alonso MM. de la Nava D, et al. Front Immunol. 2022 Apr 13;13:866892. doi: 10.3389/fimmu.2022.866892. eCollection 2022. Front Immunol. 2022. PMID: 35493490 Free PMC article. Review.
Atypical Intraparenchymal Meningioma with YAP1-MAML2 Fusion in a Young Adult Male: A Case Report and Mini Literature Review.
Nobee A, Xu M, Seth A, Rong Y. Nobee A, et al. Int J Mol Sci. 2023 Aug 15;24(16):12814. doi: 10.3390/ijms241612814. Int J Mol Sci. 2023. PMID: 37628996 Free PMC article. Review.

See all "Cited by" articles

References

1. Bleyer A, Barr R, Hayes-Lattin B, et al. The distinctive biology of cancer in adolescents and young adults. Nat. Rev. Cancer. Apr 2008;8(4):288–298. - PubMed
1. Tricoli JV, Seibel NL, Blair DG, et al. Unique characteristics of adolescent and young adult acute lymphoblastic leukemia, breast cancer, and colon cancer. J Natl Cancer Inst. Apr 20 2011;103(8):628–635. - PMC - PubMed
1. Ostrom QT, Gittleman H, Fulop J, et al. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008–2012. Neuro Oncol. Oct 2015;17(Suppl 4):iv1–iv62. - PMC - PubMed
1. Ostrom QT, de Blank PM, Kruchko C, et al. Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007–2011. Neuro Oncol. Jan 2015;16(Suppl 10):x1–x36. - PMC - PubMed
1. Lewis DR, Seibel NL, Smith AW, Stedman MR. Adolescent and young adult cancer survival. J. Natl. Cancer Inst. Monogr. Nov 2014;2014(49):228–235. - PMC - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

K12 CA076917/CA/NCI NIH HHS/United States

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- MedlinePlus Health Information